Table 3 Dialysis-related data of peritoneal dialysis patients stratified by kidney size (n = 83).

From: Impact of kidney size on mortality in diabetic patients receiving peritoneal dialysis

Variable

All patients (n = 83)

Diabetic patients with enlarged or normal kidney size (n = 67)

Diabetic patients with small kidney size (n = 16)

P value

Erythropoietin dose, unit/month

17,108.43 ± 6248.93

16,716.42 ± 6630.52

18,750.00 ± 4057.91

0.245

Dialysate/plasma creatinine

0.69 ± 0.11

0.69 ± 0.013

0.68 ± 0.029

0.822

Peritoneal equilibration test

   

0.517

High, n (%)

12 (14.5)

10 (14.9)

2 (12.5)

 

High average, n (%)

46 (55.4)

38 (56.7)

8 (50.0)

 

Low average, n (%)

21 (25.3)

15 (22.4)

6 (37.5)

 

Low, n (%)

4 (4.8)

4 (6.0)

0 (0.0)

 

Weekly Kt/Vurea

2.01 ± 0.04

2.00 ± 0.39

2.06 ± 0.39

0.896

Weekly creatinine clearance rate, L/1.73 m2

59.52 ± 15.53

60.67 ± 16.48

54.71 ± 9.67

0.170

Normalized protein nitrogen appearance, g/kg/day

1.03 ± 0.03

1.04 ± 0.03

0.99 ± 0.06

0.426

Residual kidney function, mL/min

10.66 ± 15.41

11.98 ± 16.56

5.15 ± 7.26

0.112

Cardiothoracic ratio

0.51 ± 0.06

0.51 ± 0.06

0.51 ± 0.05

0.854

  1. Residual kidney function was determined by urinary creatinine clearance using a 24-h urine collection method. Cardiothoracic ratio was measured by dividing the biggest transverse diameter of the heart silhouette by the length between the internal margins of the ribs at the level of right hemidiaphragm.